Medication Tips GLP-1 New Products: Wegovy (semaglutide) Tablets and Multi-Dose Vials of Mounjaro and Zepbound (tirzepatide) Reuters reports that Novo Nordisks new Wegovy (semaglutide) pill is a hit, with total prescriptions filled during its first full week on the market topping 18,000
TL;DR Semaglutide came off patent in India on 21 March 2026, and within a week thirteen companies had launched twenty-six generic brands
Klein KR, Menacher A, Buse JB, Mann JFE, Tuttle KR, Kvist K, Andersen MR, Mayrdorfer M, Lingvay I
How Personalized Semaglutide Dosing Restarts Weight Loss Individualized dosing strategies move beyond a one-size-fits-all approach
Overprescribing of opioids following laparoscopic hysterectomy remains a concern